Search results
Scarborough Advisors LLC Boosts Stock Holdings in Eli Lilly and Company (NYSE:LLY)
ETF DAILY NEWS· 2 days agoThe institutional investor owned 465 shares of the company’s stock after acquiring an additional 32 shares during the quarter. Scarborough Advisors LLC’s holdings in
10 Reasons to Buy Eli Lilly Stock Now
247wallst.com· 4 days agoOne such company that’s now increasingly viewed as a growth play is Eli Lilly (NYSE: LLY). With this in mind, let’s dive into the top 10 reasons...
Lilly Endowment Inc Sells 139,490 Shares of Eli Lilly and Company (NYSE:LLY) Stock
ETF DAILY NEWS· 7 days agoEli Lilly and Company (NYSE:LLY – Get Free Report) major shareholder Lilly Endowment Inc sold 139,490 shares of the firm’s stock ...
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
CNBC· 1 day agoSkyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new...
Eli Lilly and Company (NYSE:LLY) Trading Up 0.6%
ETF DAILY NEWS· 3 days agoApproximately 603,843 shares traded hands during trading, a decline of 79% from the average daily volume of 2,942,490 shares. Three analysts have rated the stock with a hold ...
DRW Securities LLC Raises Stock Holdings in Eli Lilly and Company (NYSE:LLY)
ETF DAILY NEWS· 4 days agoThe fund owned 2,420 shares of the company’s stock after purchasing an additional 1,168 shares during the period. DRW Securities LLC’s holdings in Eli & ...
Lilly Endowment Inc sells over $64 million in Eli Lilly stock By Investing.com
Investing.com· 7 days agoEli Lilly shares totaling approximately $64,997,274. Lilly Endowment Inc, which is not affiliated...
Spotlight on Eli Lilly and Co: Analyzing the Surge in Options Activity - Eli Lilly and Co (NYSE:LLY)
Benzinga· 1 day agoEli Lilly and Co's Current Market Status Currently trading with a volume of 65,069, the LLY's price is down by -0.18%, now at $876.87 ...
Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower
Investor's Business Daily· 7 days ago"Leqembi remains a safer option, and Leqembi's subcutaneous form could mitigate Lilly's dosing...
Why Eli Lilly (LLY) is a Top Momentum Stock for the Long-Term
Zacks· 6 days agoTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both ...
